May 22, 2013
An article in Time reports “a blood test may soon identify which pregnant women are at highest risk of developing postpartum depression, so [doctors] can seek treatment that could control their symptoms.” A new study found that women with postpartum depression had epigenetic modifications in their DNA. Additional research demonstrated that estrogen affected these genes. “Based on the levels of compounds made by these genes that could be picked up in the blood, these two genetic markers predicted with 85% accuracy which pregnant women went on to develop postpartum depression, and which ones did not.”
Read it in Time.
Read the study in Molecular Psychiatry.